Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centella asiatica water extract is an aqueous preparation derived from the plant Centella asiatica, also known as gotu kola or cica. It contains bioactive triterpene glycosides such as asiaticoside and madecassoside and their aglycones asiatic acid and madecassic acid. The primary mechanisms of action are believed to involve antioxidant activity, anti-inflammatory effects, enhancement of skin barrier function, and neuroprotective properties. Preclinical studies suggest benefits for cognitive health (including potential prevention or treatment of cognitive decline), wound healing, skin hydration, and reduction of oxidative stress[1][5][6]. The product is widely used in cosmetics for its moisturizing and reparative effects on the skin[6], but it is also under clinical development as a botanical drug for cognitive decline[1]. It has shown low potential for cytochrome P450-mediated drug interactions in vitro[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on centella asiatica water extract.